Biotech RadarJobs updated

COMPANY

Jaguar Gene Therapy

HQ: Lake Forest, IL source · jaguargenetherapy.com ↗ · Midwest

Clinical Phase 2

After the AAV vector delivers its genetic payload to the nucleus of a cell, the gene is then transcribed and translated to produce a functional protein. Jaguar’s first three gene therapy programs use AAV-based delivery, meaning AAV functions as a type of vehicle (or vector) used to deliver functioning genes into the target cells. From company website Source · Oct 12, 2026

Keywords: AAV gene therapy galactosemia Phelan-McDermid syndrome type 1 diabetes SHANK3 Haploinsufficiency JAG201

Location: Lake Forest, IL · source · Oct 15, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 1/Phase 2: JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT06662188JAG201 Gene Therapy Study in Children & Adults With SHANK3 HaploinsufficiencyPhase 1/Phase 2RecruitingJan 7, 20242028-06 (estimated)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Feedback